FOXO4-DRI Solubility & Diluents — Research Reference

Achieving precise and reproducible solubility for FOXO4-DRI is paramount for rigorous research outcomes. As a critical senolytic peptide, careful consideration of diluent selection, pH, and concentration protocols is essential to ensure its proper biological activity and experimental consistency across various research models.

FOXO4-DRI, classified as a senolytic peptide, functions through a mechanism involving a FOXO4-derived sequence, making it a subject of extensive study in cellular-aging research. Its significance is underscored by numerous publications indexed in PubMed and several registered studies on ClinicalTrials.gov, highlighting the widespread scientific interest in its potential research applications. Therefore, a comprehensive understanding of its solubility profile is indispensable for researchers aiming to conduct reliable and impactful studies.

Understanding FOXO4-DRI: A Senolytic Peptide in Research

FOXO4-DRI, a cutting-edge peptide extensively studied in the realm of cellular aging research, represents a significant focus for investigators exploring senolytic strategies. As a FOXO4-derived peptide, its mechanism centers on modulating cellular pathways associated with senescence, offering a unique avenue for investigating age-related cellular dysfunction. The conceptual framework underpinning its research utility stems from its proposed ability to disrupt the interaction between FOXO4 and p53, thereby influencing the survival of senescent cells. This targeted approach has garnered considerable attention, reflected in the numerous PubMed publications indexing studies on this compound and the several registered studies on ClinicalTrials.gov, underscoring its relevance as a research tool for understanding and potentially mitigating aspects of cellular aging.

The classification of FOXO4-DRI as a senolytic peptide positions it within a broader category of compounds designed to selectively induce apoptosis in senescent cells while sparing healthy, non-senescent cells. This selectivity is paramount in research contexts, as it allows for a more precise dissection of the roles of senescent cells in various physiological and pathological processes. Research applications for FOXO4-DRI span a wide spectrum, from fundamental mechanistic studies elucidating the intricate molecular biology of senescence to more translational investigations exploring its effects in diverse *in vitro* and *in vivo* models of aging and age-related conditions. Understanding its precise mechanism of action is critical for designing effective experimental protocols and interpreting results accurately, further detailed at FOXO4-DRI Mechanism of Action.

For researchers working with FOXO4-DRI, ensuring the integrity and quality of the peptide is a foundational prerequisite for reproducible and reliable experimental outcomes. The quality of the synthesized peptide, including its purity and structural authenticity, directly impacts its solubility, stability, and ultimately, its biological activity. Reputable suppliers, such as Royal Peptide Labs, provide detailed Certificates of Analysis (CoA) that confirm these critical parameters, offering transparency into the peptide’s characteristics. These Certificates of Analysis are indispensable resources for researchers, providing specific data points on purity, amino acid composition, and counterion presence, all of which can influence the peptide’s behavior in solution and its performance in various research assays. High-purity FOXO4-DRI is essential to minimize confounding variables stemming from impurities, which could otherwise interfere with experimental results or lead to inconsistent observations.

Moreover, the inherent chemical properties of FOXO4-DRI, like any research peptide, dictate its handling, storage, and preparation protocols. While the primary focus of this document is solubility, it is crucial to recognize that solubility is intrinsically linked to the peptide’s overall stability and research utility. Proper handling from the moment of receipt, typically as a lyophilized powder, through reconstitution and subsequent storage of stock solutions, is critical to preserve its structural integrity and functional efficacy. Researchers interested in broader aspects of peptide research can find general information at What are Research Peptides?, which highlights general considerations pertinent to these valuable research tools. The specific research applications of FOXO4-DRI are continuously expanding, and a comprehensive understanding of its physical and chemical properties, including its solubility profile, is foundational for advancing the scientific understanding of senolytics and their potential roles in biological research.

Fundamental Principles Governing Peptide Solubility

The solubility of a peptide in an aqueous solution is a complex physiochemical property determined by a confluence of factors, primarily stemming from its amino acid sequence, overall charge, and three-dimensional structure. Peptides, being polyampholytic molecules, contain both acidic and basic functional groups (carboxyl and amino groups, respectively), alongside a diverse array of side chains, each possessing distinct chemical properties (hydrophobic, hydrophilic, acidic, basic, polar uncharged). The interaction of these groups with the solvent molecules, typically water, dictates the peptide’s propensity to dissolve. Generally, peptides with a higher proportion of charged or polar amino acid residues tend to exhibit greater aqueous solubility compared to those rich in hydrophobic residues, which often require non-aqueous or co-solvent systems for complete dissolution. Understanding these fundamental principles is crucial for predicting and optimizing the solubility of FOXO4-DRI in various research contexts.

One of the most significant determinants of peptide solubility is the net charge of the molecule, which is highly dependent on the solution’s pH relative to the peptide’s isoelectric point (pI). At its pI, a peptide carries a net zero charge, minimizing electrostatic repulsion between molecules and often leading to decreased solubility and increased aggregation or precipitation. Conversely, at pH values significantly above or below the pI, the peptide will carry a net negative or positive charge, respectively, increasing its interaction with polar water molecules and enhancing solubility. The specific amino acid sequence of FOXO4-DRI, including the number and distribution of ionizable groups (e.g., aspartic acid, glutamic acid, lysine, arginine, histidine, tyrosine, cysteine, N-terminal amine, C-terminal carboxyl), collectively determines its pI and thus its optimal pH range for dissolution. Furthermore, the presence of specific sequences known to promote aggregation, such as amyloidogenic motifs or stretches of highly hydrophobic residues, can significantly challenge solubility, even under otherwise favorable conditions.

Key Factors Influencing Peptide Solubility:

• Amino Acid Composition and Sequence: The ratio of hydrophobic to hydrophilic residues, the presence of charged groups (acidic/basic), and the distribution of these residues along the peptide chain fundamentally determine its interaction with aqueous solvents. Peptides with a high proportion of charged amino acids (e.g., Lys, Arg, Asp, Glu) are generally more soluble in water.
• Overall Charge and Isoelectric Point (pI): The net charge of the peptide, which varies with pH, dictates its electrostatic interactions with water molecules and other peptide molecules. Solubility is typically lowest near the peptide’s pI, where the net charge is zero, and highest when the peptide is significantly charged.
• Hydrophobicity: Highly hydrophobic peptides (rich in Ala, Val, Leu, Ile, Met, Phe, Trp, Pro) have limited aqueous solubility due to their unfavorable interactions with water. These often require organic co-solvents (e.g., DMSO, acetonitrile) for initial dissolution.
• Peptide Concentration: At very high concentrations, even soluble peptides can exceed their saturation limit, leading to aggregation or precipitation. Furthermore, concentrated solutions can promote intermolecular interactions, potentially reducing solubility.
• Temperature: While increased temperature generally enhances solubility by increasing molecular kinetic energy and disrupting intermolecular interactions, extreme temperatures can also lead to peptide degradation or irreversible aggregation. Each peptide has an optimal temperature range for dissolution.
• Ionic Strength and Buffer Composition: The presence of salts and buffers can have complex effects. Low salt concentrations can sometimes enhance solubility by “salting in” charged peptides, but very high salt concentrations can lead to “salting out,” where salt ions compete with the peptide for water molecules. The choice of buffer and its ionic strength must be carefully considered.

Beyond these intrinsic properties and solution parameters, the physical state of the peptide prior to reconstitution also plays a crucial role. Lyophilized peptides, for instance, often form an amorphous or crystalline powder. The physical characteristics of this powder, such as particle size and morphology, can influence the rate of dissolution. Improper lyophilization or extended storage under suboptimal conditions can lead to irreversible aggregation or conformational changes that diminish solubility. Therefore, an integrated understanding of peptide chemistry, solution thermodynamics, and physical handling is indispensable for achieving optimal dissolution of FOXO4-DRI and ensuring its suitability for a broad range of research applications.

Characterizing FOXO4-DRI Solubility: Initial Considerations

Prior to conducting any research with FOXO4-DRI, a thorough initial characterization of its solubility profile is an indispensable step to ensure accurate and reproducible experimental outcomes. This process begins with a careful examination of the peptide as received, typically in its lyophilized powder form. The quality and purity of the peptide are paramount, as impurities (e.g., truncated sequences, oxidized forms, residual solvents, counterions from synthesis) can significantly impact solubility and subsequent experimental results. Researchers should always consult the Certificate of Analysis (CoA) provided by Royal Peptide Labs, which offers critical data on purity (often determined by High-Performance Liquid Chromatography, HPLC) and mass spectrometry confirmation of the correct molecular weight. This CoA serves as a baseline for understanding the inherent properties of the specific batch of FOXO4-DRI being utilized, and further details on the importance of quality can be found on our Quality Testing page.

The counterion associated with the peptide is another crucial initial consideration. Peptides are often supplied as trifluoroacetate (TFA) salts, remnants from their synthesis and purification process. TFA, a relatively strong acid, can acidify the solution upon reconstitution, influencing the peptide’s charge state and thus its solubility. While TFA is generally well-tolerated in many research applications, its presence can be a concern for certain cell-based assays or *in vivo* studies, particularly at higher concentrations. Alternative counterions, such as acetate or hydrochloride, may alter the pH upon dissolution and can also impact solubility. Understanding the counterion identity and its percentage by weight, as stated on the CoA, allows for informed decisions regarding initial diluent selection and potential pH adjustment strategies.

Impact of Peptide Purity and Physical State:

Even highly pure peptides can exhibit solubility challenges if their physical state is compromised. Improper lyophilization, for instance, can lead to the formation of tightly packed aggregates or a crystalline structure that dissolves slowly or incompletely. Conversely, an amorphous powder typically dissolves more readily. Visual inspection of the lyophilized powder can offer preliminary clues, though microscopic analysis would provide more definitive insights into particle morphology. Exposure to moisture or extreme temperatures during storage can also lead to partial hydration and aggregation, further complicating subsequent dissolution. Therefore, adhering strictly to recommended storage conditions for the lyophilized peptide is paramount to preserve its optimal solubility characteristics before reconstitution.

When approaching the initial reconstitution of FOXO4-DRI, it is prudent to start with a systematic approach. Rather than immediately attempting to dissolve the peptide in the final experimental buffer, a sequential dissolution strategy is often more effective. This may involve using a small volume of a strong, highly soluble solvent (e.g., DMSO, acetic acid, or a dilute acid/base solution, depending on the predicted pI) to achieve complete initial dissolution, followed by subsequent dilution into the desired aqueous buffer. This step-wise process helps overcome the initial energy barrier for dissolution and prevents the formation of aggregates that can be difficult to redissolve later. Careful monitoring of the solution’s clarity and homogeneity during this initial phase, perhaps even with low-magnification microscopy, can provide valuable feedback on the success of the dissolution and the absence of undissolved particulate matter.

Finally, the inherent chemical properties of FOXO4-DRI itself must be considered in the context of its intended research application. As a FOXO4-derived peptide, its amino acid sequence will contain specific hydrophobic and hydrophilic regions, as well as charged residues, that dictate its overall solubility profile. While specific details of its exact sequence are proprietary, the general principles of peptide chemistry apply. If initial attempts at dissolution reveal challenges, it may be necessary to refer back to its general class and known characteristics of similar peptides to troubleshoot. Factors such as the peptide’s length, the presence of D-amino acids or modifications, and its overall hydrophobicity score (if calculable) can all guide the selection of appropriate diluents and strategies for achieving target concentrations, which is especially important for *in vitro* assays where precise concentration is critical for dose-response relationships.

Selecting Optimal Diluents for FOXO4-DRI Research Applications

The selection of an optimal diluent for FOXO4-DRI is a critical decision that profoundly impacts its solubility, stability, and ultimately, its biological activity and suitability for specific research applications. No single diluent is universally ideal for all experimental contexts; rather, the choice must be carefully considered based on the peptide’s intrinsic properties, the desired stock concentration, and the downstream *in vitro* or *in vivo* experimental system. The primary goal is to achieve complete dissolution without compromising the peptide’s structural integrity or introducing elements that could interfere with the experimental model. Generally, the process involves selecting between aqueous buffers, organic co-solvents, or a combination thereof, often initiated by a primary dissolving agent followed by dilution into a physiologically relevant buffer.

Common Diluent Classes and Considerations:

1. Aqueous Buffers: For peptides that are inherently water-soluble, buffers such as phosphate-buffered saline (PBS), Tris-buffered saline (TBS), or Hanks’ Balanced Salt Solution (HBSS) are preferred. These buffers maintain physiological pH and ionic strength, making them suitable for cell culture and *in vivo* applications. The specific pH of the buffer should be chosen to maximize the net charge of FOXO4-DRI (i.e., pH far from its pI) to enhance solubility. However, highly hydrophobic peptides or those requiring very high concentrations may not fully dissolve in plain aqueous buffers alone. The buffering capacity is also critical to ensure pH stability during storage and experimental use.
2. Organic Co-solvents: For peptides with limited aqueous solubility, initial dissolution in a small volume of a strong organic solvent is often necessary.
   • Dimethyl Sulfoxide (DMSO): A highly effective solvent for many hydrophobic peptides. It is miscible with water and can be used to prepare concentrated stock solutions that are then diluted into aqueous buffers. However, DMSO can be toxic to cells at higher concentrations (typically above 0.1-1% v/v) and may alter cell membrane permeability or enzymatic activities. Purity of DMSO (molecular biology grade) is essential to avoid contaminants.
   • Dimethylformamide (DMF): Similar to DMSO in its solvating power but generally considered more toxic and less commonly used for biological applications.
   • Acetonitrile (ACN): Used less frequently for initial dissolution but can be employed, particularly for analytical purposes. It is volatile and less suitable for long-term storage of peptide solutions.
   • Acetic Acid (e.g., 0.1% to 10% v/v): Dilute acetic acid can be effective for peptides that are basic and become positively charged at low pH. It can also help break up aggregates. However, strong acidic conditions can lead to peptide degradation (e.g., aspartyl peptide bond hydrolysis) over time.
   • Hydrochloric Acid (e.g., 0.01 N to 0.1 N): Similar to acetic acid, useful for basic peptides. Caution regarding degradation applies.
   • Ammonium Hydroxide (e.g., 0.01 N to 0.1 N): Used for acidic peptides that require alkaline conditions to achieve a negative charge and enhance solubility. Strong alkaline conditions can lead to degradation (e.g., asparagine/glutamine deamidation, racemization).

When selecting a diluent for FOXO4-DRI, it is crucial to consider the potential for interactions between the peptide and the chosen solvent system. For instance, some peptides are prone to oxidation, and certain solvents (or the presence of oxygen in solution) can exacerbate this. Others may be sensitive to extreme pH conditions, leading to hydrolysis or deamidation. Therefore, the chosen diluent should not only facilitate dissolution but also contribute to the stability of the peptide over the intended period of storage and experimental use. If an organic co-solvent is employed for initial dissolution, the subsequent dilution into an aqueous buffer must be performed carefully, often by slowly adding the concentrated organic stock to the buffer while stirring, to prevent precipitation as the organic solvent concentration drops.

For research applications involving live cells or *in vivo* administration, the biocompatibility of the diluent is a paramount concern. Even if an organic solvent like DMSO is used for initial dissolution, it must be diluted to non-toxic concentrations in the final working solution. Typical maximum acceptable concentrations for DMSO in cell culture are in the range of 0.1% to 0.5% (v/v), though this can vary depending on cell type and assay sensitivity. For *in vivo* studies, the diluent must be sterile, pyrogen-free, and physiologically compatible, often necessitating solutions like sterile saline (0.9% NaCl), PBS, or specialized formulations designed for injection. The stability of FOXO4-DRI in these physiological diluents over the duration of an experiment (e.g., during continuous infusion) also requires careful assessment, as discussed further in the Storage Recommendations section and specific guidance available at FOXO4-DRI Storage and Handling.

Researchers should always perform small-scale solubility tests with various diluents and pH conditions when working with a new batch or when aiming for particularly high concentrations of FOXO4-DRI. This empirical approach helps identify the optimal balance between achieving complete dissolution and maintaining peptide integrity within the constraints of the experimental system. Factors such as the final desired concentration, the volume needed, and the duration of storage for the dissolved peptide all contribute to the complexity of diluent selection, emphasizing the need for a systematic and informed approach rather than a one-size-fits-all solution.

Strategies for Enhancing and Maintaining FOXO4-DRI Solubility

Achieving and maintaining optimal solubility of FOXO4-DRI is fundamental for the integrity and reproducibility of research experiments. Beyond the initial selection of an appropriate diluent, several practical strategies can be employed to enhance dissolution and preserve the peptide in a soluble state. These methods address various physical and chemical barriers to solubility, aiming to overcome intermolecular interactions that lead to aggregation or precipitation.

Physical Agitation and Temperature Control:

One of the most straightforward methods to aid dissolution is gentle physical agitation. This can range from careful pipetting up and down, gentle vortexing (avoiding excessive foaming, which can denature peptides), to magnetic stirring. For particularly recalcitrant peptides, brief sonication in a water bath sonicator can be highly effective. Sonication helps to break up loosely associated aggregates and ensures uniform mixing, facilitating the interaction between peptide molecules and the solvent. However, excessive or prolonged sonication should be avoided, as the energy input can potentially lead to peptide degradation or local heating. Simultaneously, controlling the temperature during dissolution is critical. While most peptides dissolve more readily at slightly elevated temperatures (e.g., 25-37°C), care must be taken to avoid temperatures that could induce denaturation or chemical degradation. It is often advisable to allow the peptide solution to equilibrate at room temperature or a slightly elevated temperature for a short period, followed by thorough mixing, and then returning it to a refrigerated state for storage.

pH Adjustment:

As previously discussed, the net charge of FOXO4-DRI is a primary determinant of its aqueous solubility. Adjusting the pH of the solution to move it away from the peptide’s isoelectric point (pI) will increase its net charge, thereby enhancing its interaction with water molecules and reducing intermolecular aggregation. For peptides that are basic (pI > 7), lowering the pH (e.g., using dilute acetic acid or HCl) will protonate basic residues (Lys, Arg, His), imparting a net positive charge. For acidic peptides (pI < 7), raising the pH (e.g., using dilute ammonium hydroxide or NaOH) will deprotonate acidic residues (Asp, Glu), imparting a net negative charge. It is crucial to make pH adjustments gradually and monitor the pH precisely using a calibrated pH meter. Overly harsh acidic or basic conditions, or rapid pH changes, can induce irreversible conformational changes or chemical degradation of the peptide. Buffers are often employed to maintain a stable pH environment after initial adjustment, ensuring solubility is maintained over time.

Utilization of Co-solvents and Additives:

For peptides with significant hydrophobic character or those requiring very high concentrations, co-solvents such as DMSO or a low percentage of ethanol or acetonitrile can be indispensable for initial dissolution. The general strategy involves dissolving the peptide in a minimal volume of the organic co-solvent to create a highly concentrated stock solution, followed by slow dilution into the desired aqueous buffer. When diluting, it is critical to add the organic stock drop-wise into the aqueous buffer while stirring, allowing the peptide to gradually transition into the new solvent environment and preventing sudden precipitation. The final concentration of the organic co-solvent in the working solution must be kept below levels that could impact biological systems (e.g., typically <0.1-1% DMSO for cell culture). Additionally, certain additives can enhance solubility by disrupting aggregation or stabilizing the peptide. These include:

• Chaotropic Agents: Guanidine hydrochloride or urea can disrupt hydrogen bonds and hydrophobic interactions, unfolding proteins and peptides to expose more soluble surfaces. However, these agents are typically incompatible with biological assays.
• Surfactants (e.g., Polysorbate 20/80, Triton X-100): At very low concentrations, non-ionic surfactants can reduce surface tension and prevent aggregation, particularly at interfaces (air-liquid, liquid-solid). Care must be taken as they can also interfere with certain assays or cell membranes.
• Arginine: Sometimes used at concentrations of 0.1-1 M to enhance solubility and prevent aggregation, particularly during refolding processes for recombinant proteins, and can be useful for challenging peptides.
• Sugars/Polyols (e.g., Sucrose, Glycerol): These can act as osmolytes, stabilizing peptide structures and improving solubility by preferential exclusion, which can prevent aggregation.

The selection of any additive should be carefully evaluated for its compatibility with the specific research application and its potential impact on FOXO4-DRI’s activity or stability. A systematic approach often involves testing several conditions on small aliquots of the peptide to identify the most effective and least interfering strategy.

Maintaining solubility after initial dissolution is just as important as achieving it. Storing dissolved FOXO4-DRI solutions in appropriate conditions, often aliquoted and frozen, minimizes freeze-thaw cycles and reduces the likelihood of aggregation over time. The choice of storage container material (e.g., low-binding polypropylene vials) can also play a role in preventing peptide adsorption to surfaces, which can lead to effective loss of concentration and potentially aggregation. By combining these physical and chemical strategies, researchers can optimize the handling of FOXO4-DRI to ensure its consistent solubility and thereby enhance the reliability and interpretability of their experimental results.

Preparation of FOXO4-DRI Stock and Working Solutions

The meticulous preparation of FOXO4-DRI stock and working solutions is a cornerstone of reliable peptide research. Accurate concentration, complete dissolution, and maintenance of stability are paramount to ensure the integrity of experimental data. This process typically begins with the lyophilized peptide and culminates in precisely measured working solutions suitable for *in vitro* or *in vivo* applications. Aseptic technique should be employed throughout, especially when solutions are intended for cell culture or animal studies, to prevent microbial contamination.

Calculations for Reconstitution and Dilution:

The first step involves calculating the precise volume of diluent required to achieve a desired stock concentration. The weight of the peptide supplied, as indicated on the Certificate of Analysis (CoA), is crucial. However, it is important to note that the provided weight includes not only the peptide itself but also any counterions (e.g., TFA, acetate) and residual water content. For highly precise research, particularly when comparing across different batches or suppliers, it is advisable to consider the peptide content by weight, if specified, or to use a molar concentration based on the peptide’s molecular weight, assuming the counterion contribution is negligible for most biological applications unless specifically indicated. If the counterion amount is substantial and known (

Frequently Asked Questions

What is the recommended primary diluent for FOXO4-DRI stock solutions?

Generally, ultrapure water or a mild acidic aqueous solution (e.g., 0.1% acetic acid) is recommended as a primary diluent for FOXO4-DRI, depending on the specific peptide formulation and desired concentration, to aid initial dissolution.

How does pH affect FOXO4-DRI solubility?

The solubility of FOXO4-DRI, like many peptides, is significantly influenced by pH, particularly around its isoelectric point (pI). Adjusting pH slightly above or below the pI can often enhance solubility by altering the charge state of ionizable residues, thus increasing electrostatic repulsion and interaction with water molecules.

Can FOXO4-DRI be dissolved directly in cell culture media?

While possible for preparing immediate working solutions, dissolving FOXO4-DRI directly in complex cell culture media for concentrated stock solutions is generally not recommended. This is due to potential interactions with media components, the complexity of verifying complete dissolution, and difficulties in achieving high concentrations or long-term stability. A concentrated stock in a simpler, well-characterized diluent is usually preferred, which is then diluted into cell culture media.

What is the typical maximum recommended concentration for FOXO4-DRI stock solutions?

The maximum recommended concentration for FOXO4-DRI stock solutions varies depending on its specific formulation, purity, and the chosen diluent. Researchers should always conduct preliminary solubility tests, but concentrations typically range from 1 to 10 mg/mL, with higher concentrations potentially requiring specific solubilization aids or specialized diluents. Exceeding solubility limits can lead to aggregation and loss of activity.

What are common methods to enhance FOXO4-DRI solubility if initial dissolution is difficult?

Methods to enhance solubility for FOXO4-DRI include gentle sonication (using a bath sonicator to avoid degradation), slight warming (e.g., to 37°C for a short duration), gradual pH adjustment using dilute acids or bases, or the judicious addition of small percentages of co-solvents like dimethyl sulfoxide (DMSO) or acetonitrile (ACN), if compatible with downstream experimental applications.

What storage conditions are optimal for dissolved FOXO4-DRI stock solutions?

Dissolved FOXO4-DRI stock solutions are typically stored at -20°C or -80°C in small, single-use aliquots to minimize freeze-thaw cycles and potential degradation. Protection from light exposure is also often recommended. Proper labeling with concentration, diluent, and date is crucial.

Is filter sterilization suitable for FOXO4-DRI solutions?

Yes, filter sterilization using a 0.22 µm syringe filter is generally suitable for FOXO4-DRI solutions, provided the peptide is fully dissolved and does not exhibit significant adsorption to the filter membrane. Researchers should perform preliminary tests to verify peptide recovery after filtration, especially for highly concentrated solutions or specific filter types.

How can researchers verify complete dissolution and prevent aggregation of FOXO4-DRI?

Verification of complete dissolution can involve visual inspection for particulates, spectrophotometric analysis to confirm concentration consistency, and more advanced techniques. Dynamic Light Scattering (DLS) is a valuable tool to assess particle size distribution and detect the presence of aggregates, while size-exclusion chromatography (SEC) can also be employed to monitor aggregation states in solution.

Scientific References

• PubMed: FOXO4-DRI senolytic
• ClinicalTrials.gov: FOXO4-DRI senolytic

All information from Royal Peptide Labs is provided for in-vitro laboratory and research use only — not for human, veterinary, diagnostic, or therapeutic use.